Course Details
Course Description
Kidney 360 – Hot Topics & Innovations in Nephrology 2026 Conference is a one-day scientific event designed to provide healthcare professionals with the latest evidence-based updates and clinical advances in nephrology. The conference covers key areas including chronic kidney disease, acute kidney injury, glomerular diseases, home dialysis, and transplant nephrology.
Through expert-led lectures, panel discussions, and case-based learning, participants will gain practical insights into modern nephrology practice, innovative therapies, and interdisciplinary patient care approaches.
The event aims to enhance clinical decision-making, improve patient outcomes, and support continuous professional development in kidney care.
SCFHS Accredited 8 CME Hours
Date, Time & Venue:
Date: Saturday, 27 June, 2026
Time: 8:00 AM – 4:00 PM
Venue: Jeddah Marriott Hotel, Madinah Road
Target Audience
Hemodialysis
Blood Transfusion Medicine
Family Medicine
Internal Medicine
Emergency Medicine
General Practice
Urology
Critical Care Medicine
Gastrointestinal Surgery
Public Health
Geriatric Medicine
Gastroenterology
Nephrology
Renal transplant
Preventive Medicine
Family and Community Medicine
Nursing
Adult Critical Care Nursing
Medical and Surgical Nursing
Nursing Administration
Primary Health Care Nursing
Hemodialysis Nursing
Geriatric Nursing
Emergency Care Nursing
Clinical Pharmacy
Pharmacy
Clinical Nutrition
Conference Chairman
Dr. Abdullah Kashgari
Dr. Abdullah Kashgari is a senior healthcare leader and consultant with extensive experience in medical education and clinical leadership. He is committed to advancing professional development and promoting excellence in interdisciplinary healthcare practice.
Scientific Committee
Dr. Nada Khalid Bashnini
Scientific Committee Chair
Consultant Nephrologist, Assistant Professor, and Head of Internal Medicine at Saudi German Hospital, Jeddah. Her interests include home dialysis and peritoneal dialysis therapies.
Prof. Saeed Al-Ghamdi
Scientific Committee Member
Senior Consultant Nephrologist at King Faisal Specialist Hospital & Research Centre, Jeddah, and Regional Medical Director at Diaverum Health Services. Prof. Al-Ghamdi is recognized for his contributions to nephrology education, dialysis care, and clinical research.
Dr. Hanadi Maatouq S. Alhozali
Scientific Committee Member
Professor and Consultant Nephrologist at King Abdulaziz University Hospital, Jeddah, with expertise in glomerular diseases and renal disease in pregnancy. She is actively involved in nephrology education and research.
Dr. Mohanad Khalid Almaimani
Scientific Committee Member
Consultant Nephrologist and Assistant Professor at the University of Jeddah with expertise in glomerular diseases and evidence-based nephrology practice.
Speakers
Prof. Saeed Al-Ghamdi
Senior Consultant Nephrologist and academic leader with extensive experience in nephrology, dialysis care, and medical education.
Dr. Hanadi Maatouq S. Alhozali
Professor and Consultant Nephrologist specializing in glomerular diseases and renal disease in pregnancy.
Dr. Yasir Adnan Alfi
Consultant Nephrologist at King Faisal Specialist Hospital & Research Centre, Jeddah, specializing in transplant nephrology and fellowship training.
Dr. Abdulaziz Ihsan Bari
Associate Consultant in Adult Transplant Nephrology at King Faisal Specialist Hospital & Research Centre, Jeddah, with interests in kidney transplantation and transplant immunology.
Dr. Nada Khalid Bashnini
Consultant Nephrologist and Assistant Professor with expertise in home dialysis and peritoneal dialysis therapies.
Dr. Mohanad Khalid Almaimani
Consultant Nephrologist and Assistant Professor specializing in glomerular diseases and nephrology education.
For inquiries, please contact: [email protected]
What will you learn?
Discuss current opportunities and future directions for nephrology training and fellowship development in Saudi Arabia and the Arab world, including educational standards, subspecialty pathways, and regional collaboration.
Evaluate the newest evidence on sodium-glucose co-transporter-2 inhibitors, non-steroidal mineralocorticoid receptor antagonists, and glucagon-like peptide-1 receptor agonists in slowing chronic kidney disease progression.
Review the latest KDIGO guidelines for the diagnosis and management of anaemia of CKD, with particular emphasis on the clinical role, indications, and safety profile of hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors.
Discuss the newest international guidelines for the prevention, diagnosis, and management of acute kidney injury (AKI), including recent advances in AKI biomarkers, subclinical AKI detection, and emerging management strategies.
Evaluate the role of established and emerging biomarkers in the early detection, risk stratification, and management of AKI in hospitalised and critically ill patients.
Apply current evidence-based diagnostic and therapeutic approaches to IgA nephropathy in light of recent landmark trials and newly approved targeted therapies.
Review updates in the diagnosis and management of lupus nephritis, including induction and maintenance regimens and the role of newer biologic and targeted therapies.
Describe the pathophysiology, diagnostic approach, and emerging complement-targeted therapeutic strategies for C3 glomerulopathy.
Define the principles, indications, prescription, and evidence base for incremental peritoneal dialysis as a strategy to preserve residual kidney function and improve patient-centred outcomes.
Discuss the challenges and barriers affecting peritoneal dialysis programme growth and patient/technique survival in Saudi Arabia, and identify strategies to improve uptake, outcomes, and long-term sustainability.
Evaluate recent advances in paired kidney exchange programmes and desensitization protocols, and their role in expanding access to living donor kidney transplantation.
Discuss the clinical utility of donor-derived cell-free DNA (dd-cfDNA) in rejection surveillance following kidney transplantation, including indications, performance characteristics, and integration into post-transplant care.
Apply risk stratification frameworks and therapeutic strategies for the prevention and management of recurrence of focal segmental glomerulosclerosis (FSGS) in the renal allograft.
Sessions in the Course
Scientific Program
Kidney 360° – Hot Topics & Innovations in Nephrology 2026 Conference
A comprehensive nephrology conference advancing excellence in CKD, dialysis, transplant nephrology, and AKI through evidence-based updates and multidisciplinary care.CPD ProgramsKidney 360° – Hot Topics & Innovations in Nephrology 2026 Conference
A comprehensive nephrology conference advancing excellence in CKD, dialysis, transplant nephrology, and AKI through evidence-based updates and multidisciplinary care.
CPD ProgramsThis course includes:
- Course Dates: From 2026-06-27to2026-06-28
- Duration: 8 hours
- Days: 1 days
- Enrollments: 1 enrollment
- Level: All Levels
- 149 seat left
